Extra funding for nanomaterials for cancer immunotherapy research
The DFG has agreed to fund the Mainz-based Collaborative Research Center involved in the development of nanomaterials for cancer immunotherapy...
List view / Grid view
The DFG has agreed to fund the Mainz-based Collaborative Research Center involved in the development of nanomaterials for cancer immunotherapy...
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
Researchers at Aalto University, Finland, have developed anticancer nanomaterials by simulating the volcano-induced dynamic chemistry of the deep ocean.
Scientists have developed a novel nanodiamond-based contrast agent - a chemical "dye" used to enhance the visibility of internal body structures in magnetic resonance imaging - that improves visualisation of liver cancer tumours...
Swedish researchers at Chalmers University of Technology and Sahlgrenska Academy have successfully induced human cartilage cells to live and grow in an animal model, using 3D bioprinting.
Enzyme therapy is a promising form of cancer treatment. The specific nature of enzyme and substrate interaction gives enzyme therapy an edge compared to standard non-specific therapies such as radiation and chemotherapy. However, since most of these enzymes are of a foreign nature, the delivery of these immunogenic enzymes has…
How do tumours grow? And how do bacteria transform harmless substances into medical agents? When biophysicists want to understand what is happening in living cells, they have to introduce fluorescent probes or other foreign molecules. There are several ways to overcome the cell wall without causing the cell permanent harm.
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The fibre optics research at KTH covers everything from bio-implants via medical sensors to solar cells and the researchers aim to have developed several...
17 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The extension agreement will trigger a €1 million payment to Ablynx, and MSD will extend their funding of the research collaboration to September 2018...
14 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Over the course of six months, scientists at OCSiAl, Envigo and InterTek collaborated to conduct extensive research and testing on potentially hazardous...